Vault-13

SABBY MANAGEMENT, LLC

MIAMI BEACH, FL · CIK 1535610 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$12.0m reported value +110.5% vs Q1 2026
16positions
94.7%in top 10
8 new 4 added 4 reduced 14 sold out vs Q1 2026

Options: 3 call positions ($29.7m notional), 4 put positions ($68.8m notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SPDR S&P 500 ETF TR TR UNIT SPY SPY 5,500 $4.1m34.17% 34.17% AddedShares held: Q3 2025 0, Q4 2025 335, Q1 2026 2.7k, Q2 2026 5.5k +2.8k +2,766 101.2%
2 TOYO CO LTD ORD SH TOYO TOYO 503,846 $3.5m29.13% 29.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 503.8k
3 FARMMI INC SHS NEW FAMI FAMI 3,515,929 $840.3k6.99% 6.99% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.5m
4 CERVOMED INC COM CRVO CRVO 248,880 $771.5k6.42% 6.42% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 248.9k
5 TEMPEST THERAPEUTICS INC COM NEW TPST TPST 511,286 $567.5k4.72% 4.72% AddedShares held: Q3 2025 0, Q4 2025 178.6k, Q1 2026 17.9k, Q2 2026 511.3k +493.4k +493,430 2763.4%
6 PARANOVUS ENTERTNMNT TECH LT CL A ORD SHS PAVS PAVS 75,440 $560.5k4.66% 4.66% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 75.4k
7 BIOAFFINITY TECHNOLOGIES INC COM NEW COM NEW 365,647 $296.9k2.47% 2.47% NewShares held: Q3 2025 242.8k, Q4 2025 0, Q1 2026 0, Q2 2026 365.6k
8 SMART POWERR CORP COM CREG CREG 127,774 $263.2k2.19% 2.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 127.8k
9 BRIACELL THERAPEUTICS CORP COM BCTX BCTX 80,721 $261.5k2.18% 2.18% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 73.9k, Q2 2026 80.7k +6.8k +6,806 9.2%
10 REVELATION BIOSCIENCES INC COM 2025 COM 2025 210,582 $216.9k1.80% 1.80% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 99.4k, Q2 2026 210.6k +111.2k +111,150 111.8%
11 SENESTECH INC COM NEW SNES SNES 141,756 $211.2k1.76% 1.76% ReducedShares held: Q3 2025 71.3k, Q4 2025 210.6k, Q1 2026 218.5k, Q2 2026 141.8k -76.8k -76,777 -35.1%
12 BRIACELL THERAPEUTICS CORP *W EXP 01/15/203 BCTXL BCTXL 190,383 $169.4k1.41% 1.41% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 380.7k, Q2 2026 190.4k -190.3k -190,303 -50.0%
13 SIDUS SPACE INC CL A COM NEW SIDU SIDU 43,377 $121.9k1.01% 1.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 43.4k
14 INMED PHARMACEUTICALS INC COM NEW INM INM 44,970 $69.7k0.58% 0.58% ReducedShares held: Q3 2025 220.0k, Q4 2025 201.6k, Q1 2026 220.3k, Q2 2026 45.0k -175.3k -175,290 -79.6%
15 NUWELLIS INC COM NEW NUWE NUWE 16,372 $49.9k0.42% 0.42% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 16.4k
16 BRIACELL THERAPEUTICS CORP *W EXP 99/99/999 BCTXZ BCTXZ 120,802 $11.5k0.10% 0.10% ReducedShares held: Q3 2025 374.5k, Q4 2025 266.0k, Q1 2026 206.8k, Q2 2026 120.8k -86.0k -85,951 -41.6%

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
PORTAGE BIOTECH INC ALP ALP 2,072,103 $654.8k2.1m shares
BIG TREE CLOUD HLDGS LTD DSY DSY 137,611 $337.1k137.6k shares
TOKEN CAT LTD TC TC 23,239 $241.7k23.2k shares
POP CULTURE GROUP CO LTD CPOP CPOP 664,449 $201.1k664.4k shares
MOLECULIN BIOTECH INC 75,021 $171.8k75.0k shares
BIODEXA PHARMACEUTICALS PLC 257,472 $159.1k257.5k shares
ARCADIA BIOSCIENCES INC RKDA RKDA 114,554 $158.1k114.6k shares
TRX GOLD CORPORATION TRX TRX 100,000 $150.0k100.0k shares
CAN FITE BIOFARMA LTD CANF CANF 42,559 $131.9k42.6k shares
CHINA SXT PHARMACEUTICALS IN SXTC SXTC 78,170 $131.3k78.2k shares
CALIDI BIOTHERAPEUTICS INC 434,903 $103.9k434.9k shares
BLUEJAY DIAGNOSTICS INC BJDX BJDX 28,726 $52.9k28.7k shares
LYRA THERAPEUTICS INC LYRA LYRA 104,059 $51.1k104.1k shares
BNB PLUS CORP BNBX BNBX 13,541 $8.7k13.5k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR S&P 500 ETF TR SPY · Put SPYPut 725 $54.1m725 shares Added
SPDR S&P 500 ETF TR SPY · Call SPYCall 205 $15.3m205 shares New
ISHARES TR IJJ · Call IJJCall 442 $13.3m442 shares New
ISHARES TR Put Put 441 $13.2m441 shares Added
ABIVAX SA ABVX · Call ABVXCall 82 $1.1m82 shares Added
SIDUS SPACE INC SIDU · Put SIDUPut 2,905 $816.3k2.9k shares Added
ZEVRA THERAPEUTICS INC ZVRA · Put ZVRAPut 427 $612.3k427 shares Added

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
APPLIED DNA SCIENCES INC 13G · filed 2025-01-03 10.0% new 13G 2025-01-03
FOXO Technologies Inc 13G · filed 2026-01-21 9.9% new 13G 2026-01-21
GLOBAVEND HOLDINGS LIMITED GVH · 13G · filed 2026-01-21 GVH 9.9% new 13G 2026-01-21
TEMPEST THERAPEUTICS INC TPST · 13G · filed 2026-01-21 TPST 9.9%≈ $546.3k new 13G 2026-01-21
ORAGENICS INC OGEN · 13G · filed 2026-01-21 OGEN 9.9%≈ $241.2k new 13G 2026-01-21
JIUZI HOLDINGS INC JZXN · 13G · filed 2026-01-21 JZXN 9.9% no change 13G 2026-01-21
INMED PHARMACEUTICALS INC INM · 13G · filed 2026-01-20 INM 9.9%≈ $434.2k new 13G 2026-01-20
LYRA THERAPEUTICS INC LYRA · 13G · filed 2026-01-20 LYRA 9.9% new 13G 2026-01-20
BIODEXA PHARMACEUTICALS PLC 13G · filed 2026-01-20 9.9% new 13G 2026-01-20
UNIVERSE PHARMACEUTICALS INC 13G · filed 2025-01-03 9.9% new 13G 2025-01-03
CYNGN INC 13G · filed 2025-01-03 9.9% 13G 2025-01-03
TRANSCODE THERAPEUTICS INC 13G · filed 2025-01-03 9.9% new 13G 2025-01-03
VOLCON INC 13G · filed 2025-01-03 9.9% new 13G 2025-01-03
REVELATION BIOSCIENCES INC 13G · filed 2026-01-20 9.6% new 13G 2026-01-20
BIG TREE CLOUD HLDGS LTD DSY · 13G · filed 2026-01-20 DSY 6.6% new 13G 2026-01-20
NUWELLIS INC 13G · filed 2026-01-20 5.4% new 13G 2026-01-20